◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Biocon Limited (BIOCON)

Name: Biocon Limited（BIOCON）— 財務諸表の推移
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Healthcare · ウォール街（米国） · 最終更新: 2026-11-01

Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments.

主要指標

時価総額: ₹576 billion
売上高（2026-03-31 期末の会計年度）: ₹167.8B
当期純利益: ₹3.9B
売上総利益率: 66.1%
純利益率: 2.3%

インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→

年次損益計算書

損益計算書	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31
売上高合計	₹172.1B	₹167.8B	₹150.5B	₹142.0B	₹109.3B
売上総利益	₹114.6B	₹110.9B	₹98.5B	₹92.9B	₹72.7B
営業利益（EBIT）	₹14.9B	₹17.2B	₹16.3B	₹14.3B	₹16.3B
当期純利益	₹5.0B	₹3.9B	₹10.1B	₹10.2B	₹4.6B

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は BIOCON のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/BIOCON

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.